HSA | FSA CARDS ARE NOW ACCEPTED

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Understanding PTGS2 and Osteoarthritis Risk

Arthritis causes joint inflammation, pain, stiffness, and swelling. Osteoarthritis is the most common form and results from gradual cartilage breakdown and joint wear over time. The PTGS2 gene makes the COX-2 enzyme, a key driver of inflammation in joints. Variations in PTGS2 can change COX-2 activity and influence inflammation, cartilage health, and long-term joint function.

How PTGS2 Affects Joint Health

COX-2 is involved in the body’s inflammatory response. Higher or dysregulated COX-2 activity can increase inflammatory signaling in joint tissues, which may accelerate cartilage breakdown and raise the risk of osteoarthritis. Genetic variation at rs4140564 in PTGS2 is one marker linked to altered COX-2 activity and differing osteoarthritis risk profiles.

What This Means for You

A genetic predisposition does not determine outcome. Lifestyle, body weight, prior joint injury, activity choices, and other genes all contribute to whether osteoarthritis develops and how it progresses. Genetic information is a tool to guide prevention and health choices that support long-term joint function.

Actionable Steps to Support Joint Health

Diet

  • Follow an anti-inflammatory eating pattern centered on whole foods: plenty of vegetables, fruits, legumes, nuts, seeds, and whole grains.
  • Include fatty fish such as salmon, mackerel, sardines, or plant sources of omega-3s like flaxseed and chia to help modulate inflammatory pathways.
  • Limit processed foods, added sugars, and excessive refined carbohydrates that promote systemic inflammation.
  • Favor sources of antioxidants and polyphenols — berries, leafy greens, green tea, and colorful vegetables — to support tissue repair and counter oxidative stress.

Supplements to Consider

  • Omega-3 fatty acids (EPA and DHA): can reduce inflammatory mediators linked to cartilage breakdown.
  • Turmeric (curcumin): has anti-inflammatory effects and may help reduce joint discomfort; use formulations with enhanced absorption.
  • Glucosamine and chondroitin: commonly used to support cartilage structure and joint comfort; responses vary between individuals.
  • Vitamin D: maintain sufficient levels for bone and muscle health; low vitamin D is associated with poorer musculoskeletal outcomes.
  • Before starting any supplement, discuss dosing, interactions, and safety with your healthcare provider.

Lifestyle Recommendations

  • Maintain a healthy weight: reducing excess load on weight-bearing joints lowers mechanical stress and inflammation.
  • Engage in regular low-impact exercise: walking, swimming, cycling, and water aerobics support joint mobility and muscle strength without excessive wear.
  • Include strength training to preserve and build muscle around joints for stability and shock absorption.
  • Prioritize joint-sparing movement patterns and proper footwear to reduce repetitive joint stress.
  • Manage pain and inflammation with nonpharmacologic strategies: heat, cold, physical therapy, and activity modification as needed.

Monitoring and Clinical Considerations

  • Keep a record of joint symptoms, activity levels, and triggers to discuss with your clinician.
  • Check vitamin D status and correct deficiency if present.
  • If you experience persistent joint pain or progressive symptoms, seek evaluation for imaging, physical therapy, or medical management options.

Genetic Interpretation

2 effect alleles (GG) — Increased risk

You carry two copies of the effect allele at rs4140564 (GG). This genotype is associated with a higher genetic predisposition to osteoarthritis compared to other variants at this marker. Your PTGS2 variation may alter COX-2 enzyme production or regulation, potentially increasing joint inflammation and accelerating cartilage breakdown. This is a relative risk increase, not a diagnosis. Many people with this genotype never develop significant osteoarthritis, especially if they maintain healthy weight, use joint-protective exercise, and follow anti-inflammatory lifestyle practices.

Practical steps: prioritize weight management, regular low-impact exercise, omega-3–rich foods or supplements, consider turmeric/curcumin for inflammation, and discuss glucosamine or chondroitin with your clinician. Monitor symptoms and seek early care for joint pain or injury.

1 effect allele (AG) — Moderately increased risk

You carry one copy of the effect allele at rs4140564 (AG). This genotype suggests a modestly elevated predisposition to osteoarthritis relative to individuals without the effect allele. PTGS2-related effects on COX-2 may contribute to higher inflammatory signaling in joints in some people, but this is only one of many influencing factors.

Practical steps: adopt anti-inflammatory eating habits, maintain healthy body weight, include omega-3s and antioxidant-rich foods, engage in regular low-impact exercise and strength training, and consider targeted supplements after consulting your healthcare provider. Early attention to joint symptoms and injury prevention can help reduce long-term risk.

0 effect alleles (AA) — Typical risk

You carry two copies of the non-effect allele at rs4140564 (AA). This is the most common pattern and indicates that, at this specific PTGS2 marker, you do not have the variant associated with increased COX-2 activity. Your genetic risk related to this marker is similar to the general population.

Practical steps: even with typical genetic risk, osteoarthritis can still occur due to age, weight, injury, and lifestyle. Follow anti-inflammatory dietary principles, maintain a healthy weight, stay active with low-impact and strength-building exercise, and address joint symptoms early. Preventive habits support joint health for everyone.

Putting Information Into Practice

Genetic testing at PTGS2 offers insight into one pathway that influences joint inflammation and osteoarthritis risk. Use this information to prioritize preventive strategies: reduce excess joint load, choose anti-inflammatory foods, support musculoskeletal strength, and address early symptoms promptly. Personalized choices and consistent lifestyle habits can make a meaningful difference in long-term joint health.

Important Disclaimer

PlexusDx does not provide medical advice. This information is educational and intended to help you understand genetic predispositions related to joint health. Always consult with your healthcare provider before changing diet, starting supplements, or making clinical decisions based on genetic results. Your clinician can interpret genetic results in the context of your medical history, medications, and overall health.

If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:

🧬 Genetic Tests:

🧪 Blood Tests:

📄 Genetic Report:

Frequently Asked Questions About ARTHRITIS and PTGS2 rs4140564

What does the PTGS2 rs4140564 variant mean for my osteoarthritis risk?

The PTGS2 gene helps produce the COX-2 enzyme, which drives inflammatory signaling in joints. The rs4140564 marker is linked to altered COX-2 activity, which may influence inflammation and cartilage health over time. In PlexusDx interpretation, having 2 effect alleles (GG) suggests increased genetic predisposition to osteoarthritis, AG suggests a moderately increased risk, and AA suggests typical risk—relative risk only, not a diagnosis.

How does PTGS2 (COX-2) inflammation affect cartilage breakdown?

COX-2 is involved in the body’s inflammatory response. When COX-2 activity is higher or dysregulated in joint tissues, it can increase inflammatory signaling that may accelerate cartilage breakdown. PTGS2 variation at rs4140564 may contribute to differing inflammation levels in individuals, which can affect long-term joint function and osteoarthritis risk profiles.

What lifestyle and supplement steps can help reduce osteoarthritis risk if I have the effect allele?

A genetic predisposition does not determine outcome. Weight management, low-impact exercise (like walking, swimming, cycling), strength training, and joint-sparing movement and proper footwear can lower joint load and inflammation. An anti-inflammatory diet rich in vegetables, fruits, legumes, nuts, seeds, whole grains, and omega-3 sources (fatty fish or chia/flax) may help. Supplements often considered include omega-3s (EPA/DHA), turmeric/curcumin, glucosamine and chondroitin, and vitamin D—discuss dosing, interactions, and safety with your healthcare provider. Track symptoms and seek evaluation if pain persists or worsens.

What tests can help me learn more about ARTHRITIS and PTGS2 rs4140564?

The Longevity and Healthy Aging Genetic Test delivers over 200 genetic insights related to cellular repair, inflammation balance, metabolism, cardiometabolic health, and aging pathways. The Healthy Aging Genetic Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.